Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/14/2014 08/15/2014 08/18/2014 08/19/2014 08/20/2014 Date
90.37(c) 90.88(c) 91.3(c) 91.92(c) 91.3(c) Last
1 156 441 1 053 292 1 147 810 894 155 1 071 383 Volume
+1.83% +0.56% +0.46% +0.68% -0.67% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 554 M
EBIT 2014 -652 M
Net income 2014 -706 M
Finance 2014 402 M
Yield 2014 -
Sales 2015 1 405 M
EBIT 2015 131 M
Net income 2015 42,9 M
Finance 2015 1 048 M
Yield 2015 -
PER 2014 -
PER 2015 534,54
EV / Sales 2014 38,5x
EV / Sales 2015 14,7x
Capitalization 21 737 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
1d ago VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Solid Forms of ..
1d ago VERTEX PHARMACEUTICALS : Patent Issued for Isothiazolopyridinones Useful for the..
6d ago VERTEX PHARMACEUTICALS : Assigned Patent
08/13 Biotechs lift Wall Street; Dow back in black for 2014
08/13DJMARKET SNAPSHOT : U.S. Stocks Push Higher; Biotechs Rally
08/13 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry Described by Invest..
08/11 S&P 500 MOVERS : Vrtx, kmi
08/11 NASDAQ 100 MOVERS : Ilmn, tsla
08/08 VERTEX PHARMACEUTICALS : Assigned Patent
08/06 VERTEX PHARMACEUTICALS : Receives European Approval for KALYDECO™ ivacafto..
08/06 VERTEX PHARMACEUTICALS : Patent Application Titled "Dosage Units of 3-(6-(1-(2,2..
07/31 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF